日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations

MEK 抑制是针对携带 RAS 突变的 MLL 重排婴儿急性淋巴细胞白血病患者的一种有前景的治疗策略

Mark Kerstjens, Emma M C Driessen, Merel Willekes, Sandra S Pinhanços, Pauline Schneider, Rob Pieters, Ronald W Stam

CBL mutations do not frequently occur in paediatric acute myeloid leukaemia

CBL 突变在儿童急性髓系白血病中并不常见

Eva A Coenen, Emma M C Driessen, C Michel Zwaan, Jan Stary, Andre Baruchel, Valerie de Haas, Eveline S J M de Bont, Dirk Reinhardt, Gertjan J L Kaspers, Susan T C J M Arentsen-Peters, Claus Meyer, Rolf Marschalek, Rob Pieters, Ronald W Stam, Marry M van den Heuvel-Eibrink